8-K: 180 Life Sciences Corp. Changes Auditors and Receives $1.5 Million Insurance Payout

180 Life Sciences Corp. has changed its independent auditor from Marcum LLP to M&K CPAs, PLLC and received a $1.5 million net payment from an insurance claim.

Summary

• 180 Life Sciences Corp. dismissed Marcum LLP as their independent auditor and engaged M&K CPAs, PLLC, effective April 17, 2024.
• Marcum's audit reports for 2022 and 2023 did not contain any adverse opinions, but did disclose an uncertainty about the company's ability to continue as a going concern.
• There were no disagreements between 180 Life Sciences and Marcum regarding accounting principles or auditing scope.
• The company received a $2.27 million payment from AmTrust related to a prior insurance claim, netting $1.5 million after legal fees.
• The company is still pursuing further claims against AmTrust and Freedom Specialty Insurance Company related to the same insurance policy.

Sentiment

Score: 5

Explanation: The document contains both positive and negative elements. The insurance payment is a positive, but the change of auditors and the going concern uncertainty are negatives. The ongoing litigation also adds risk.

Positives

• The company successfully received a $1.5 million net payment from AmTrust, resolving part of a long-standing insurance dispute.
• The court has ruled in favor of the company on key issues related to the insurance claim, indicating a strong legal position.
• The change in auditors was approved by the Audit Committee, suggesting proper corporate governance.

Negatives

• Marcum's audit reports for 2022 and 2023 disclosed an uncertainty about the company's ability to continue as a going concern.
• The company is still involved in ongoing litigation with AmTrust and Freedom, which could result in further legal expenses and uncertainty.
• The company had to pay legal fees to receive the $1.5 million payment, reducing the total amount received.

Risks

• The company's ability to continue as a going concern is still uncertain, as noted in the previous auditor's reports.
• Ongoing litigation with AmTrust and Freedom could result in further legal expenses and may not be successful.
• The company may not recover the full amount of its claimed expenses from the insurance companies.

Future Outlook

The company intends to continue to vigorously pursue the remaining issues in the insurance litigation to establish its entitlement to full payment by both AmTrust and Freedom.

Management Comments

• The company believes the Court ruling in its favor in regards to the matters discussed above is a significant positive outcome for the Company.
• The company intends to continue to vigorously pursue this final matter in order to establish the company's entitlement to full payment by both AmTrust and Freedom of the subject advancement expenses of the company.

Industry Context

Changes in auditors are not uncommon, but the circumstances surrounding the change, including the going concern uncertainty, may raise concerns for investors. The insurance litigation is also a significant event, as it involves a substantial claim and could impact the company's financial position.

Comparison to Industry Standards

• The change of auditors is not unusual, but the fact that the previous auditor raised concerns about the company's ability to continue as a going concern is a significant issue.
• Many companies in the biotech sector face litigation, but the size of the claim and the fact that the company has already received a partial payment is notable.
• The legal process and the court's partial ruling in favor of the company is similar to other cases where insurance companies try to avoid paying out on policies.

Legal Proceedings

• The company is involved in ongoing litigation with AmTrust and Freedom Specialty Insurance Company related to a directors and officers insurance policy.
• The company received a partial payment of $2.27 million from AmTrust, with a net of $1.5 million after legal fees.
• The company is still pursuing further claims against both AmTrust and Freedom.

Stakeholder Impact

• Shareholders may be concerned about the going concern uncertainty and the ongoing litigation.
• Employees may be affected by the company's financial situation and the outcome of the litigation.
• Creditors may be concerned about the company's ability to repay its debts.

Next Steps

• The company will continue to pursue the remaining issues in the insurance litigation.
• The company will work with its new auditor, M&K CPAs, PLLC, for the fiscal year ending December 31, 2024.

Key Dates

Keywords

auditor, insurance, litigation, Marcum LLP, M&K CPAs, AmTrust, Freedom Specialty Insurance, going concern, legal, financial